These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16445443)

  • 1. A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.
    Lindblom B; Nordmann JP; Sellem E; Chen E; Gold R; Polland W; Williamson W; Buchholz P; Walt JG; Groleau D; Curry A; Evans SJ
    Acta Ophthalmol Scand; 2006 Feb; 84(1):74-83. PubMed ID: 16445443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States.
    Kobelt-Nguyen G; Gerdtham UG; Alm A
    J Glaucoma; 1998 Apr; 7(2):95-104. PubMed ID: 9559495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of glaucoma in clinical practice: four-year results from a patient registry in France.
    Kobelt G; Texier-Richard B; Buchholz P; Bron A; Renard JP; Rouland JF; Nordmann JP
    J Glaucoma; 2010 Mar; 19(3):199-206. PubMed ID: 19661825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An observational, retrospective two-year cost study in primary open-angle glaucoma and ocular hypertension in newly diagnosed patients].
    Rouland JF; Peigne G; Sellem E; Renard JP; Williamson W; Filippi JM; Cohn H; Hamard P; Abellan P; Chagnon A; Malet F; Haye I
    J Fr Ophtalmol; 2001 Mar; 24(3):233-43. PubMed ID: 11285438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glaucoma in the United States and europe: predicting costs and surgical rates based upon stage of disease.
    Lee PP; Kelly SP; Mills RP; Traverso CE; Walt JG; Doyle JJ; Katz LM; Siegartel LR;
    J Glaucoma; 2007 Aug; 16(5):471-8. PubMed ID: 17700290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.
    Lee PP; Walt JG; Doyle JJ; Kotak SV; Evans SJ; Budenz DL; Chen PP; Coleman AL; Feldman RM; Jampel HD; Katz LJ; Mills RP; Myers JS; Noecker RJ; Piltz-Seymour JR; Ritch RR; Schacknow PN; Serle JB; Trick GL
    Arch Ophthalmol; 2006 Jan; 124(1):12-9. PubMed ID: 16401779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study.
    Gieser DK; Tracy Williams R; O'Connell W; Pasquale LR; Rosenthal BP; Walt JG; Katz LM; Siegartel LR; Wang L; Rosenblatt LC; Stern LS; Doyle JJ
    J Glaucoma; 2006 Oct; 15(5):419-25. PubMed ID: 16988605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of resource utilization in the treatment of open-angle glaucoma between two cities in Finland: is more better?
    Hagman J
    Acta Ophthalmol; 2013 May; 91 Thesis 3():1-47. PubMed ID: 23621767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
    Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
    Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of patients with ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.
    Rosenbaum LJ
    Am J Ophthalmol; 2007 Jan; 143(1):191-2; author reply 192-3. PubMed ID: 17188074
    [No Abstract]   [Full Text] [Related]  

  • 11. Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany.
    Lorenz K; Wolfram C; Breitscheidel L; Shlaen M; Verboven Y; Pfeiffer N
    Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):2019-28. PubMed ID: 23624617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist.
    Peeters A; Schouten JS; Webers CA; Prins MH; Hendrikse F; Severens JL
    Eye (Lond); 2008 Mar; 22(3):354-62. PubMed ID: 17128205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension.
    Walt JG; Lee JT
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S36-44. PubMed ID: 15016560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of treating ocular hypertension.
    Stewart WC; Stewart JA; Nasser QJ; Mychaskiw MA
    Ophthalmology; 2008 Jan; 115(1):94-8. PubMed ID: 18166406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries.
    Holmstrom S; Buchholz P; Walt J; Wickstrøm J; Aagren M
    Curr Med Res Opin; 2006 May; 22(5):897-905. PubMed ID: 16709311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical costs of glaucoma and ocular hypertension in Italian referral centres: a prospective study.
    Koleva D; Motterlini N; Schiavone M; Garattini L;
    Ophthalmologica; 2007; 221(5):340-7. PubMed ID: 17728557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care charges for patients with ocular hypertension or primary open-angle glaucoma.
    Pasquale LR; Dolgitser M; Wentzloff JN; Stern LS; Doyle JJ; Chiang TH; Walt JG
    Ophthalmology; 2008 Apr; 115(4):633-638.e4. PubMed ID: 17716736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between mean intraocular pressure, disease stability and cost of treating glaucoma in Canada.
    Vicente C; Walker J; Buys Y; Einarson TR; Covert D; Iskedjian M
    Curr Med Res Opin; 2004 Aug; 20(8):1245-51. PubMed ID: 15324527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma.
    Jayawant SS; Bhosle MJ; Anderson RT; Balkrishnan R
    J Glaucoma; 2007 Sep; 16(6):513-20. PubMed ID: 17873711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.